mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α

被引:222
作者
Cam, Hakan [1 ,2 ]
Easton, John B. [2 ]
High, Anthony [3 ]
Houghton, Peter J. [1 ,2 ]
机构
[1] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH 43205 USA
[2] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA
[3] St Jude Childrens Hosp, Hartwell Ctr Biotechnol, Memphis, TN 38105 USA
关键词
MESSENGER-RNA TRANSLATION; TUMOR-SUPPRESSOR COMPLEX; DNA-DAMAGE RESPONSE; CELL-GROWTH; TUBEROUS SCLEROSIS; GENE-PRODUCT; ACTIVATION; KINASE; TARGET; TSC2;
D O I
10.1016/j.molcel.2010.10.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mTOR complex-1 (mTORC1) coordinates cell growth and metabolism, acting as a restriction point under stress conditions such as low oxygen tension (hypoxia). Hypoxia suppresses mTORC1 signaling. However, the signals by which hypoxia suppresses mTORC1 are only partially understood, and a direct link between hypoxia-driven physiological stress and the regulation of mTORC1 signaling is unknown. Here we show that hypoxia results in ataxia telangiectasia mutated (ATM)-dependent phosphorylation of hypoxia-inducible factor 1-alpha (HIF-1 alpha) on serine(696) and mediates downregulation of mTORC1 signaling. Deregulation of these pathways in pediatric solid tumor xenografts suggests a link between mTORC1 dysregulation and solid tumor development and points to an important role for hypoxic regulation of mTORC1 activity in tumor development.
引用
收藏
页码:509 / 520
页数:12
相关论文
共 59 条
[1]   A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets [J].
Arsham, AM ;
Howell, JJ ;
Simon, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29655-29660
[2]   Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1α and intracellular reactive oxygen species [J].
Ateghang, B ;
Wartenberg, M ;
Gassmann, M ;
Sauer, H .
JOURNAL OF CELL SCIENCE, 2006, 119 (06) :1043-1052
[3]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[4]   Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].
Bartkova, Jirina ;
Rezaei, Nousin ;
Liontos, Michalis ;
Karakaidos, Panagiotis ;
Kletsas, Dimitris ;
Issaeva, Natalia ;
Vassiliou, Leandros-Vassilios F. ;
Kolettas, Evangelos ;
Niforou, Katerina ;
Zoumpourlis, Vassilis C. ;
Takaoka, Munenori ;
Nakagawa, Hiroshi ;
Tort, Frederic ;
Fugger, Kasper ;
Johansson, Fredrik ;
Sehested, Maxwell ;
Andersen, Claus L. ;
Dyrskjot, Lars ;
Orntoft, Torben ;
Lukas, Jiri ;
Kittas, Christos ;
Helleday, Thomas ;
Halazonetis, Thanos D. ;
Bartek, Jiri ;
Gorgoulis, Vassilis G. .
NATURE, 2006, 444 (7119) :633-637
[5]   ATM Activation and Signaling under Hypoxic Conditions [J].
Bencokova, Zuzana ;
Kaufmann, Muriel R. ;
Pires, Isabel M. ;
Lecane, Philip S. ;
Giaccia, Amato J. ;
Hammond, Ester M. .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (02) :526-537
[6]   PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR [J].
Bernardi, Rosa ;
Guernah, Ilhem ;
Jin, David ;
Grisendi, Silvia ;
Alimonti, Andrea ;
Teruya-Feldstein, Julie ;
Cordon-Cardo, Carlos ;
Simon, M. Celeste ;
Rafii, Shahin ;
Pandolfi, Pier Paolo .
NATURE, 2006, 442 (7104) :779-785
[7]   Hypoxia, DNA repair and genetic instability [J].
Bristow, Robert G. ;
Hill, Richard P. .
NATURE REVIEWS CANCER, 2008, 8 (03) :180-192
[8]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[9]   A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin [J].
Browne, GJ ;
Proud, CG .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2986-2997
[10]   Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [J].
Brugarolas, J ;
Lei, K ;
Hurley, RL ;
Manning, BD ;
Reiling, JH ;
Hafen, E ;
Witter, LA ;
Ellisen, LW ;
Kaelin, WG .
GENES & DEVELOPMENT, 2004, 18 (23) :2893-2904